Myriad Genetics
MYGN
#7319
Rank
HK$4.10 B
Marketcap
HK$42.80
Share price
-1.44%
Change (1 day)
-14.61%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2026 (TTM): -HK$10.66

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is -HK$10.66. In 2025 the company made an earnings per share (EPS) of -HK$30.89 a decrease over its 2024 EPS that were of -HK$11.05.

EPS history for Myriad Genetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$10.66-65.48%
2025-HK$30.89179.43%
2024-HK$11.05-55.94%
2023-HK$25.08130.22%
2022-HK$10.90275.68%
2021-HK$2.90-87.99%
2020-HK$24.14755.56%
2019-HK$2.82-194.74%
2018HK$2.98-79.89%
2017HK$14.82112.36%
2016HK$6.98-35.97%
2015HK$10.90-7.33%
2014HK$11.76-37.24%
2013HK$18.7359.33%
2012HK$11.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
HK$21.20-298.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-HK$41.70 291.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-HK$0.71-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-HK$399.00 3,642.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
HK$299.13-2,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA